Peregrine Pharmaceuticals, Inc. today reported positive results from its Phase II trial evaluating bavituximab in combination with docetaxel in patients with advanced breast cancer.

Being informed on prevention is key to good health; unfortunately today, by some, prevention is being diluted into what it is not. A few years ago, the term 'prevention' was rarely part of the vocabulary in orthodox medicine; lately it

October is Breast Cancer Awareness Month, and while it is critically important to raise awareness of breast cancer prevention in general; it is also a particularly important time for us ALL -- whether we are physicians, research scientists, women, or

Millennium: The Takeda Oncology Company today announced the initiation of a Phase II clinical trial examining rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) with or without VELCADE(R) (bortezomib) for Injection for patients with a common type of lymphoma. The study

British medical scientists say they've demonstrated that unusual metal compounds can be used to form effective cancer drugs. Researchers at the University of Leeds and the University of Warwick said such metals can form an effective treatment against colon and

Exercise may protect against both memory-loss and depressive mood after whole-brain radiation treatments, U.S. researchers say. The study, presented at the Society for Neuroscience annual meeting in Chicago, found mice with access to an exercise wheel less likely to suffer

Decades of studies have documented the link between eating a diet rich in vegetables and multiple health benefits, yet nearly eight out of 10 people worldwide fall short of the daily recommendation.(1) Research presented at the International Symposium on Human

Warfarin, one of the most inconvenient, dangerous, and disliked drugs in the world, has remained vitally important for more than 50 years. That tells you how much difficulty scientists have had coming up with safer, easier pills to do what

Prostate cancer is the most commonly diagnosed and second leading cause of cancer deaths in men in the United States. If detected early, prostate cancer treatment is highly successful, but at present there are no known treatments for advanced metastatic

Nanosphere, Inc., a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that a research team at Northwestern University's International Institute for Nanotechnology found that an ultrasensitive nanoparticle-based assay, 300 times more sensitive than commercial immunoassays,

The U.S. Food and Drug Administration (FDA) on Monday approved Cervarix, a new vaccine to prevent cervical cancer and precancerous lesions caused by human papillomavirus (HPV) types 16 and 18. The vaccine is approved for use in girls and women

Lymphomas are the most common hematologic malignancies in the United States, accounting for up to 5% of all new cancer cases. As a group, they are the fifth leading cause of cancer deaths. Since the landmark report released in 1832

The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American

U.S. scientists say drugs being tested for treatment of a variety of allergies, asthma and autoimmune diseases might lead to the development of breast cancer.

Bionovo Inc. announced today the publication of results from its study on the inhibitory effect of tamoxifen on estrogen receptor beta (ERb) gene regulation. The results of the study, which will be published in Molecular and Cellular Endocrinology, demonstrate that

Mayo Clinic researchers have found that certain structural features within breast tissue can indicate a woman's individual cancer risk. The findings appear online today in the Journal of Clinical Oncology.

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005. Votrient is an oral medication that interferes with angiogenesis, the growth of new blood vessels needed for solid tumors

Today, Lung Cancer Alliance (LCA) announced the launch of the Shine a Light National Lung Cancer Vigil, a campaign designed to raise awareness of lung cancer during November, Lung Cancer Awareness Month. Building on the success of vigils held across

Although evidence suggests that aspirin and celecoxib may reduce the risk of colorectal cancer (CRC), these drugs can also cause harmful side effects. The aim of this study was to characterize patient preferences for celecoxib and aspirin, scientists in the

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX(R) [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16